Johnson & Johnson Vision has launched Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day Multifocal contact lenses for presbyopia to the UK market.
The new contact lenses are designed to address the increased daily demands on eyes and feature what the company describes as an unprecedented combination of new technologies: TearStable Technology and OptiBlue.
TearStable Technology is said to maximise tear-film stability and lock in moisture for exceptional all-day comfort, while the OptiBlue light filter is said to have the highest-level blue-violet light filter in the industry at 60% helping reduce light scatter and increase visual clarity during the day and night.
The importance of the new lenses is underscored by research conducted by Johnson & Johnson that found the majority (81%) of Brits who wear vision correction (either contact lenses or glasses) are using at least five different digital screens per day.
More than two-thirds of respondents (67%) said the increased role of screens in modern life was negatively impacting their eye comfort, and 72% said they are concerned about shielding their eyes from blue light. The vast majority of this group (80%) said they would be interested in purchasing contact lenses that would help filter it.
‘We pride ourselves in working with eye care professionals to ensure we are continually adapting and innovating to support patient needs,’ said Jakob Sveen, managing director of Northern Europe and general manager of UK & Ireland at Johnson & Johnson Vision.
‘The feedback, currently, is that patients are experiencing increased strain on their eyes as a result of longer days and increased time looking at digital devices. We’re proud to bring Acuvue Oasys Max 1-Day as an option to anyone experiencing this additional fatigue.’
